Stay updated on Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page
- CheckyesterdayChange DetectedMilestone dates for the study were updated to reflect revised timelines, including the primary completion date and the estimated study completion. The date of the most recent update was added.SummaryDifference0.3%

- Check9 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3. This indicates a minor CMS update that does not modify study details or other substantive content on the page.SummaryDifference0.1%

- Check16 days agoChange DetectedFooter revision tag updated from v3.6.0 to v3.6.2, indicating a software version update for the page.SummaryDifference0.1%

- Check30 days agoChange DetectedNew page sections were added: No longer looking for participants, How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention/Treatment header was added and the previous Intervention / Treatment header removed; the site revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check37 days agoChange DetectedThe page revision metadata was updated to v3.5.5, replacing the previous v3.5.4. This indicates a minor update to the study record display.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision updates were applied to the page, introducing new revision tags (v3.5.4) and prior version (v3.5.3) with associated dates. They reflect maintenance/version control rather than substantive changes to the trial details.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.